Precision Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Precision Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

  • March 2022 •
  • 145 pages •
  • Report ID: 6247131 •
  • Format: PDF
The global precision medicine market reached a value of US$ 61.0 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 112.8 Billion by 2027, exhibiting at a CAGR of 10.1% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Precision medicine is a medical approach to prevent and diagnose diseases by relying on an individual variability of genes, environment, and lifestyle. It assists in predicting the susceptibility to a disease, improving disease detection and progression, customizing strategies, and prescribing effective drugs. It also aids in making associated healthcare decisions, improving care quality, and eliminating trial-and-error inefficiencies. Moreover, as it reduces the time, cost, and failure rate of pharmaceutical clinical trials, precision medicine is widely utilized in diagnosing chromosomal abnormalities of the fetus and cancer, guiding therapy for chronic diseases and predicting the risk of passing on genetic disorders to offspring.

Precision Medicine Market Trends:
At present, there is a considerable rise in the use of precision medicine techniques to understand the coronavirus disease (COVID-19) susceptibility, measure its impact, and discover potential therapies. This represents one of the key factors strengthening the growth of the market. Apart from this, due to the increasing prevalence of cancer and the growing number of drug candidates under clinical trials, there is a surge in need for precision medicine methods across the globe. This, in confluence with the significantly improving healthcare infrastructure worldwide and continuous funding in research and development (R&D) activities, is contributing to market growth. Furthermore, leading players are introducing cost-effective, cutting-edge techniques, such as whole-genome sequencing and targeted sequencing, which find extensive applications in the study of genomes and the creation of personalized therapies for treating different illnesses. This, along with the rising adoption of big data in precision medicine that helps analyze the patient electronic health record and provide improved clinical decision support, is creating a favorable market outlook.

Key Market Segmentation:
the analyst provides an analysis of the key trends in each sub-segment of the global precision medicine market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, technology, application and end user.

Breakup by Product:
Consumables
Instruments
Services

Breakup by Technology:
Big Data Analytics
Bioinformatics
Gene Sequencing
Drug Discovery
Companion Diagnostics
Others

Breakup by Application:
Oncology
Central Nervous System (CNS)
Immunology
Respiratory Medicine
Infections
Others

Breakup by End User:
Hospitals and Clinics
Diagnostic Centers
Pharma and Biotech Companies
Healthcare IT Firms
Others

Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AstraZeneca plc, Bayer AG, bioMérieux SA, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Merck KGaA, Novartis AG, Pfizer Inc., Qiagen N.V., Quest Diagnostics Incorporated and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:
How has the global precision medicine market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global precision medicine market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global precision medicine market and who are the key players?
What is the degree of competition in the industry?

Our reports have been used by over 10K customers, including:

2231/3m 2231/bio-merieux 2231/bloommedical 2231/innovaderma 2231/lg 2231/medtronic 2231/merck 2231/pfizer 2231/roche 2231/samsung-medison 2231/selecta 2231/seoul-national-university 2231/world-health 2376/accenture 2376/airbnb 2376/allianz 2376/bcg 2376/deloitte 2376/enac 2376/ing-direct 2376/kpmg 2376/mit 2376/pc 2376/roland-berger 2376/united-states-post 2376/university-of-leeds 2376/visa 2267/3m 2267/air-liquide 2267/basf 2267/beaulieu 2267/bmw 2267/bosh 2267/bouygues 2267/chemistry 2267/essilor 2267/exxon-mobile 2267/general-motors 2267/georgia-pacific 2267/honeywell 2267/kodak 2267/nissan 2267/saint-gobain 2267/shell 2267/siemens 2267/spie 2000/ferrero 2000/dr-schar 2055/comtech 2055/google 2055/intelsat 2055/microsoft 2055/viacom 2055/visa 2055/warner 2055/yandex 2114/canon 2114/pg 2114/samsonite 2114/samsung 2231/3m 2231/bio-merieux 2231/bloommedical 2231/innovaderma 2231/lg

Related reports and data

Early Toxicity Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

2192 2499 1949
142 pages • By IMARC Group • Jun 2022

The global early toxicity testing market reached a value of US$ 1.08 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 1.79 Billion by 2027, exhibiting a CAGR of 8.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the...

  • Pharmaceutical
  • Drug Development
  • Cosmetics
  • Public Health
  • Clinical Trial
  • Biochemical
  • World

Cell Separation Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

2192 2499 1949
147 pages • By IMARC Group • Jun 2022

The global cell separation technologies market reached a value of US$ 7.62 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 19.28 Billion by 2027, exhibiting a CAGR of 16.10% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well...

  • Pharmaceutical
  • Biotechnology
  • Chronic Disease
  • Healthcare
  • Research And Development
  • Cystic Fibrosis
  • Infectious Disease
  • Drug Development
  • Cell Therapy
  • World

Automated Liquid Handling Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

2192 2499 1949
145 pages • By IMARC Group • Apr 2022

The global automated liquid handling market reached a value of US$ 910.1 Million in 2021. Looking forward, the analyst expects the market to reach a value of US$ 1,501.4 Million by 2027, exhibiting a CAGR of 8.40% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well...

  • Drug Development
  • Genomics
  • Genome Sequencing
  • Targeted Therapy
  • Robotics
  • World
  • Employment Costs

Global Bcr-Abl Inhibitor Market, Drug Sales & Clinical Trials Insight 2028

2631 3000 2340
240 pages • By Kuick Research • Apr 2022

Global Bcr-Abl Inhibitor Market, Drug Sales & Clinical Trials Insight 2028 Report Highlights: • Global Bcr-Abl Inhibitor Market Opportunity > USD 8 Billion • Approved Bcr-Abl Inhibitor Drugs: 8 Drugs • Global Bcr-Abl Inhibitor Market Regional Analysis & Forecast Till 2028 • Bcr-Abl Inhibitor Drug Market Past...

  • Pharmaceutical
  • Leukemia
  • Drug Development
  • Clinical Trial
  • Research And Development
  • Targeted Therapy
  • World
  • Drug Approval

Trauma Fixation Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies,2022 Update

3508 4000 3120
357 pages • By GlobalData • May 2022

Trauma Fixation Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies,2022 Update Summary Medical Devices sector report, “Trauma Fixation Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and...

  • Drug Development
  • Clinical Trial

Preclinical Research Outsourcing Services: Global Markets

4824 5500 4290
147 pages • By BCC Research • May 2022

Report Scope: This report identifies the global preclinical research outsourcing services market, along with all major global preclinical CRO companies.The total preclinical research outsourcing services market is segmented globally and by geographic regions. The service areas provided by preclinical CROs are extensively...

  • Pharmaceutical
  • Drug Development
  • Clinical Trial
  • World

Organ-on-chip Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

2192 2499 1949
146 pages • By IMARC Group • Jun 2022

The global organ-on-chip market reached a value of US$ 34.52 Million in 2021. Looking forward, the analyst expects the market to reach a value of US$ 201.13 Million by 2027, exhibiting a CAGR of 31.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...

  • Healthcare
  • Drug Development
  • Research And Development
  • Respiratory Disease
  • Molecular Biology
  • Nanobiotechnology
  • Cell Therapy
  • Biochemical
  • Tissue Engineering
  • World

In Vitro Toxicology Testing Market by Product, Toxicity Endpoints, Technology, Method, Industry - Global Forecast to 2027

4404 4950 3906
356 pages • By MarketsandMarkets • Jun 2022

The in vitro toxicology testing market is expected to reach USD 18.6 billion by 2027 from an estimated USD 11.2 billion in 2022, at a CAGR of 10.8%. Factors such as, technological advancements, and increasing R&D expenditure to detect toxicity at an early stage during drug development are the factors to drive the market The...

  • Genomics
  • Research And Development
  • Drug Development
  • Cosmetics
  • World
  • United States

Formulation Development Outsourcing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

2192 2499 1949
145 pages • By IMARC Group • Mar 2022

The global formulation development outsourcing market reached a value of US$ 21.1 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 31.8 Billion by 2027, exhibiting at a CAGR of 6.3% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as...

  • Pharmaceutical
  • Drug Development
  • Chronic Disease
  • Healthcare
  • World
  • Chronic Disease Prevalence
  • Health Expenditure

Green and Bio-Solvents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

2192 2499 1949
144 pages • By IMARC Group • Apr 2022

The global green and bio-solvents market reached a value of US$ 11 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 18.1 Billion by 2027, exhibiting a CAGR of 8.3% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well...

  • Printing Inks
  • Research And Development
  • Drug Development
  • Dietary Supplement
  • Soybean Oil
  • World